| Literature DB >> 23612370 |
Abstract
The predatory marine gastropod Dicathais orbita has been the subject of a significant amount of biological and chemical research over the past five decades. Natural products research on D. orbita includes the isolation and identification of brominated indoles and choline esters as precursors of Tyrian purple, as well as the synthesis of structural analogues, bioactivity testing, biodistributional and biosynthetic studies. Here I also report on how well these compounds conform to Lipinski's rule of five for druglikeness and their predicted receptor binding and enzyme inhibitor activity. The composition of mycosporine-like amino acids, fatty acids and sterols has also been described in the egg masses of D. orbita. The combination of bioactive compounds produced by D. orbita is of interest for further studies in chemical ecology, as well as for future nutraceutical development. Biological insights into the life history of this species, as well as ongoing research on the gene expression, microbial symbionts and biosynthetic capabilities, should facilitate sustainable production of the bioactive compounds. Knowledge of the phylogeny of D. orbita provides an excellent platform for novel research into the evolution of brominated secondary metabolites in marine molluscs. The range of polarities in the brominated indoles produced by D. orbita has also provided an effective model system used to develop a new method for biodistributional studies. The well characterized suite of chemical reactions that generate Tyrian purple, coupled with an in depth knowledge of the ecology, anatomy and genetics of D. orbita provide a good foundation for ongoing natural products research.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23612370 PMCID: PMC3705410 DOI: 10.3390/md11041370
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1(a) The development of Tyrian purple in the hypobranchial gland of Dicathais orbita; (b) The transfer of reduced precursors from the capsule gland of females to the egg capsules and the oxidation of precursors in the prostate gland of male D. orbita.
Biosynthetic enzymes proposed to be involved in the production of Tyrian purple precursors. The order of enzyme reactions generating the bromo and methylthio derivatives is not known.
| Precursor/Substrate | Enzyme | Product |
|---|---|---|
| Tryptophan | Trytophanase | Indole |
| Indole | Dioxygenases | Indoxyl sulfate |
| Indole/Indoxyl sulfate | Bromoperoxidase | 6 Bromoindole/Indoxyl |
| (6 Bromo) Indoxyl sulfate | Sulfur transferase & Sulfur reductase | (6 Bromo) Methylthio indolone/Tyrindoxyl sulfate |
| Tyrindoxyl sulfate | Aryl sulfatase | Tyrindoxyl |
(A)
| Compound | MW/Formula | Log | Polar surface area/volume | No. non-H atoms | No. H bond acceptors b | No. H bond donors c | Rotatable bonds | No. rule of 5 violations d |
|---|---|---|---|---|---|---|---|---|
| Tyrindoxyl sulfate | 337.196 | −0.346 | 82.224/211.287 | 17 | 5 | 1 | 3 | 0 |
| Tyrindoxyl | 258.14 | 3.375 | 36.019/173.614 | 13 | 2 | 2 | 1 | 0 |
| 6 Bromoisatin | 226.029 | 1.615 | 49.933/141.457 | 12 | 3 | 1 | 0 | 0 |
| Tyrindoleninone | 256.124 | 2.889 | 29.963/168.021 | 13 | 2 | 0 | 1 | 0 |
| Tyrindolinone | 304.234 | 2.999 | 29.098/208.356 | 15 | 2 | 1 | 2 | 0 |
| Tyriverdin | 514.264 | 4.66 | 58.196/334.697 | 26 | 4 | 2 | 3 | 1 |
| Tyrian purple 6,6′ dibromoindigo | 420.06 | 4.47 | 65.724/259.728 | 22 | 4 | 2 | 0 | 0 |
| 6,6′ Dibromoindirubin | 420.06 | 4.47 | 65.724/259.728 | 22 | 4 | 2 | 0 | 0 |
(B)
| Compound | MW/Formula | Log
| Polar surface area/volume | No. non-H atoms | No. H bond acceptors b | No. H bond donors c | Rotatable bonds | No. rule of 5 violations d |
|---|---|---|---|---|---|---|---|---|
| Murexine | 224.284 | −3.373 | 54.988/219.763 | 16 | 5 | 1 | 5 | 0 |
| Senecoiycholine | 186.275 | −2.096 | 26.305/200.647 | 13 | 3 | 0 | 5 | 0 |
| Tigloylcholine | 186.275 | −2.33 | 26.305/200.647 | 13 | 3 | 0 | 5 | 0 |
| Choline | 104.173 | −4.236 | 20.228/120.158 | 7 | 2 | 1 | 2 | 0 |
a Log p is based on octanol-water partition coefficient; b H bond acceptors include O & N atoms; c H bond donors include OH and NH groups; d Rule of 5 violations are based on the molecular descriptors used by Lipinski et al. [56] for “drug-like” molecules (log p ≤ 5, molecular weight ≤500, number of hydrogen bond acceptors ≤10, and number of hydrogen bond donors ≤5).
(A)
| Compound | GPCR ligand | Ion channel modulator | Kinase inhibitor | Nuclear receptor ligand | Protease inhibitor | Enzyme inhibitor | Other known bioactivity |
|---|---|---|---|---|---|---|---|
| Tyrindoxyl sulfate | 0.22 * | 0.02 | −0.13 | −0.36 | 0.10 | 0.73 ** | - |
| Tyrindoxyl | −0.56 | −0.09 | −0.41 | −0.71 | −1.00 | −0.11 | Unstable in O2 |
| 6 Bromoisatin | −1.08 | −0.49 | −0.50 | −1.62 | −1.07 | −0.39 | Anticancer, induces apoptosis, anti-bacterial [ |
| Tyrindoleninone | −0.93 | −0.39 | −0.69 | −1.16 | −1.15 | −0.43 | Anticancer, induces apoptosis, anti-bacterial [ |
| Tyrindolinone | −0.87 | −0.54 | −0.89 | −1.03 | −0.93 | −0.51 | Unstable in O2 |
| Tyriverdin | −0.23 | −0.23 | −0.29 | −0.34 | −0.17 | −0.17 | Bacteriostatic, inhibits FDA hydrolysis [ |
| Tyrian purple 6,6′ Dibromoindigo | −0.32 | −0.30 | 0.22 * | −0.05 | −0.36 | −0.01 | Highly insoluble, no apparent antibacterial or anticancer activity [ |
| 6,6′ Dibromoindirubin | −0.78 | −0.74 | 0.45 * | −0.28 | −0.61 | 0.01 | GSK-3 inhibitor [ |
(B)
| Compound | GPCR ligand | Ion channel modulator | Kinase inhibitor | Nuclear receptor ligand | Protease inhibitor | Enzyme inhibitor | Other known bioactivity |
|---|---|---|---|---|---|---|---|
| Murexine | 0.38 * | 0.50 * | −0.16 | −1.70 | −0.36 | 0.84 ** | Neuromuscular blocking and nicotinic action. No muscarinic effects. Paralysis of the skeletal musculature, toxic to mice at high doses (i.v. LD50 8.5 mg/kg, s.c. LD50 = 50 mg/kg); human clinical dose (EC50 = 1 mg/kg) [ |
| Senecoiycholine | −0.39 | 0.33 * | −1.04 | −1.28 | −0.95 | 0.35 * | Neuromuscular blocking and nicotinic action. No muscarinic effects [ |
| Tigloylcholine | −0.45 | 0.32 * | −1.37 | −1.31 | −1.35 | 0.41 * | Toxic to mice (i.v. LD50 = 0.92 mg/kg) [ |
| Choline | −2.64 | −2.21 | −3.84 | −4.93 | −3.94 | −2.18 | Essential nutrient, precursor for the neurotransmitter acetyl choline [ |
# Larger value bioactivity scores indicate a higher probability that the molecule will be active; * potential activity; ** high potential activity.